The document, published under the Accelerating Clinical Trials in the EU (ACT EU) initiative, sets out how trials should be conducted when health emergencies disrupt normal research operations
ShunzymeX leverages a proprietary protease to streamline purification
The system also introduces Imaging Scanner Interface 2 (ISI2) capability, enabling direct communication between injector and scanner to improve exam coordination and operational efficiency
The announcement follows a record-setting $1.2 million accelerated LineaDNA order
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
This multi-year CDMO agreement involves significant, ongoing manufacturing for a global pharmaceutical major
This transaction fundamentally strengthens Scinai's CDMO platform
Subscribe To Our Newsletter & Stay Updated
